(203) 914-1900 30 BUXTON FARM ROAD, STE. 230 STAMFORD, CT 06905


March 11, 2021
New and highly specific migraine drugs have significantly changed the clinical landscape for patients. We talked with Peter McAllister, MD, about where the research goes next. Therapy for migraine is having a type of research renaissance that began in late 2019 with the rapid and sequential approval by the US FDA of 4 injectable agents...
Read More